April 11th 2024
Phillip J. Koo, MD, discusses the clinical use of PSMA PET imaging in patients with prostate cancer.
March 26th 2024
Phillip J. Koo, MD, discusses the use of PSMA PET imaging in prostate cancer.
March 1st 2023
Phillip J. Koo, MD, discusses ongoing areas of technological and therapeutic advancements within the prostate cancer landscape.
August 23rd 2021
An interpretation of the OSPREY study of 18F-DCFPyL injection in patients with high-risk prostate cancer and implications of its use.
A discussion regarding the use of PSMA PET imaging to detect phenotypic biomarkers that may simplify approaches to precision medicine in advanced prostate cancer.
May 16th 2020
Phillip J. Koo, MD, discusses the need for next-generation imaging in prostate cancer.
January 29th 2020
Phillip J. Koo, MD, division chief of Diagnostic Imaging, Banner MD Anderson Cancer Center, discusses the actionability of next-generation imaging results in prostate cancer.
January 21st 2020
Phillip J. Koo, MD, division chief of Diagnostic Imaging, Banner MD Anderson Cancer Center, discusses the use of metastasis-directed therapy in prostate cancer.
November 21st 2019
Phillip J. Koo, MD, discusses new management strategies for patients with prostate cancer.
October 25th 2019
Phillip J. Koo, MD, discusses next-generation imaging tools in prostate cancer.